Virtus Fund Advisers’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,438
Closed -$28.7K 109
2022
Q4
$28.7K Buy
+1,438
New +$27.8K 0.21% 82
2017
Q4
$358K Buy
+11,494
New +$340K ﹤0.01% 390
2017
Q3
Sell
-15,662
Closed -$270K 503
2017
Q2
$270K Sell
15,662
-12,371
-44% -$211K ﹤0.01% 376
2017
Q1
$491K Sell
28,033
-1,810
-6% -$27.9K ﹤0.01% 324
2016
Q4
$395K Hold
29,843
﹤0.01% 363
2016
Q3
$433K Hold
29,843
﹤0.01% 354
2016
Q2
$301K Buy
29,843
+10,241
+52% +$119K ﹤0.01% 377
2016
Q1
$248K Sell
19,602
-4,231
-18% -$55.6K ﹤0.01% 392
2015
Q4
$433K Sell
23,833
-250
-1% -$4.4K ﹤0.01% 357
2015
Q3
$447K Sell
24,083
-35,771
-60% -$893K ﹤0.01% 350
2015
Q2
$1.46M Buy
59,854
+16,986
+40% +$386K 0.01% 336
2015
Q1
$892K Sell
42,868
-3,989
-9% -$70.3K 0.01% 362
2014
Q4
$725K Buy
46,857
+227
+0.5% +$3.22K 0.01% 388
2014
Q3
$609K Sell
46,630
-3,024
-6% -$45.6K ﹤0.01% 420
2014
Q2
$992K Buy
+49,654
New +$735K 0.01% 454

Other funds holding INSM

Virtus Fund Advisers's INSM Position: Q1 2023 in Review

Virtus Fund Advisers sold out of Insmed (INSM) in Q1 2023, closing a stake of 1,438 shares — an estimated $28.7K sold.

Virtus Fund Advisers first reported a position in INSM in Q2 2014 and held it in 15 quarters. The position peaked at $1.46M in Q2 2015. 230 funds tracked by Wall St. Rank hold INSM as of Q1 2023.

  • Virtus Fund Advisers reported no remaining Insmed position as of Q1 2023 after selling out during the quarter.
  • Virtus Fund Advisers sold 1,438 Insmed shares in Q1 2023, an estimated $28.7K.
  • Virtus Fund Advisers first reported a position in Insmed in Q2 2014 and held it in 15 quarters.
  • Virtus Fund Advisers's Insmed position peaked at $1.46M in Q2 2015.
  • 230 funds tracked by Wall St. Rank held Insmed as of Q1 2023.

Based on Virtus Fund Advisers's 13F filing for Q1 2023, filed 15 May 2023.